NO148376C - Analogifremgangsmaate til fremstilling av terapeutisk virksomme 7-acylamino-3-halogen-cefalosporinforbindelser - Google Patents

Analogifremgangsmaate til fremstilling av terapeutisk virksomme 7-acylamino-3-halogen-cefalosporinforbindelser

Info

Publication number
NO148376C
NO148376C NO740607A NO740607A NO148376C NO 148376 C NO148376 C NO 148376C NO 740607 A NO740607 A NO 740607A NO 740607 A NO740607 A NO 740607A NO 148376 C NO148376 C NO 148376C
Authority
NO
Norway
Prior art keywords
acylamino
halogen
preparation
therapeutic activity
analogy procedure
Prior art date
Application number
NO740607A
Other languages
English (en)
Norwegian (no)
Other versions
NO148376B (no
NO740607L (no
Inventor
Robert Raymond Chauvette
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO740607L publication Critical patent/NO740607L/no
Publication of NO148376B publication Critical patent/NO148376B/no
Publication of NO148376C publication Critical patent/NO148376C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/02Preparation
    • C07D501/04Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/59Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3 with hetero atoms directly attached in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO740607A 1973-02-23 1974-02-22 Analogifremgangsmaate til fremstilling av terapeutisk virksomme 7-acylamino-3-halogen-cefalosporinforbindelser NO148376C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33541473A 1973-02-23 1973-02-23

Publications (3)

Publication Number Publication Date
NO740607L NO740607L (no) 1974-08-26
NO148376B NO148376B (no) 1983-06-20
NO148376C true NO148376C (no) 1983-09-28

Family

ID=23311677

Family Applications (2)

Application Number Title Priority Date Filing Date
NO740607A NO148376C (no) 1973-02-23 1974-02-22 Analogifremgangsmaate til fremstilling av terapeutisk virksomme 7-acylamino-3-halogen-cefalosporinforbindelser
NO792609A NO792609L (no) 1973-02-23 1979-08-10 3-halogencefalosporinforbindelser for bruk som mellomprodukter ved fremstilling av terapeutisk virksomme forbindelser

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO792609A NO792609L (no) 1973-02-23 1979-08-10 3-halogencefalosporinforbindelser for bruk som mellomprodukter ved fremstilling av terapeutisk virksomme forbindelser

Country Status (34)

Country Link
JP (4) JPS612677B2 (xx)
AR (3) AR208068A1 (xx)
AT (1) AT333952B (xx)
BE (1) BE811494A (xx)
BG (1) BG22404A3 (xx)
BR (1) BR7401385D0 (xx)
CA (1) CA1032532A (xx)
CH (1) CH594686A5 (xx)
CS (1) CS189625B2 (xx)
CY (1) CY1042A (xx)
DD (1) DD110277A5 (xx)
DE (1) DE2408686C2 (xx)
ES (1) ES423532A1 (xx)
FI (1) FI63240C (xx)
FR (1) FR2218878B1 (xx)
GB (1) GB1458293A (xx)
GT (1) GT197432132A (xx)
HK (1) HK19980A (xx)
HU (1) HU167749B (xx)
IE (1) IE38916B1 (xx)
IL (1) IL44263A (xx)
KE (1) KE3026A (xx)
MW (1) MW574A1 (xx)
MY (1) MY8100023A (xx)
NL (1) NL181010C (xx)
NO (2) NO148376C (xx)
OA (1) OA04688A (xx)
PH (1) PH14014A (xx)
PL (1) PL88714B1 (xx)
RO (1) RO64595A (xx)
SE (1) SE411211B (xx)
YU (2) YU36971B (xx)
ZA (1) ZA741190B (xx)
ZM (1) ZM3674A1 (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT342197B (de) * 1975-02-20 1978-03-28 Ciba Geigy Ag Neues verfahren zur herstellung von 3-cephemverbindungen
CH622802A5 (xx) * 1975-08-20 1981-04-30 Ciba Geigy Ag
IE45158B1 (en) * 1976-08-16 1982-06-30 Lilly Co Eli 3-chloro-cephem synthesis
PH17188A (en) * 1977-03-14 1984-06-14 Fujisawa Pharmaceutical Co New cephem and cepham compounds and their pharmaceutical compositions and method of use
JPS62112053U (xx) * 1985-12-27 1987-07-16
JPH0676861B2 (ja) * 1988-05-24 1994-09-28 リンナイ株式会社 温風暖房機の制御装置
IT1255458B (it) * 1992-05-11 1995-11-02 Col Marco Da Procedimento per la preparazione di derivati beta-lattamici alogenati

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2143211B1 (xx) * 1971-06-24 1975-10-31 Fujisawa Pharmaceutical Co

Also Published As

Publication number Publication date
CA1032532A (en) 1978-06-06
FR2218878A1 (xx) 1974-09-20
JPS49116095A (xx) 1974-11-06
FI63240B (fi) 1983-01-31
AT333952B (de) 1976-12-27
BE811494A (fr) 1974-08-22
DD110277A5 (xx) 1974-12-12
MY8100023A (en) 1981-12-31
KE3026A (en) 1980-03-14
JPS613356B2 (xx) 1986-01-31
IE38916B1 (en) 1978-06-21
NO148376B (no) 1983-06-20
NL7402486A (xx) 1974-08-27
JPS612677B2 (xx) 1986-01-27
JPS56138193A (en) 1981-10-28
IL44263A0 (en) 1974-05-16
SE411211B (sv) 1979-12-10
JPS613357B2 (xx) 1986-01-31
BG22404A3 (xx) 1977-02-20
GT197432132A (es) 1975-08-16
RO64595A (ro) 1981-01-30
NL181010C (nl) 1987-06-01
DE2408686C2 (de) 1986-08-28
DE2408686A1 (de) 1974-09-05
GB1458293A (en) 1976-12-15
MW574A1 (en) 1975-05-13
HU167749B (xx) 1975-12-25
YU99880A (en) 1983-04-27
PH14014A (en) 1980-12-08
AR200908A1 (es) 1974-12-27
NO740607L (no) 1974-08-26
OA04688A (fr) 1980-07-31
AR208068A1 (es) 1976-11-30
IL44263A (en) 1977-10-31
CY1042A (en) 1980-08-01
AR201709A1 (es) 1975-04-08
JPS56138195A (en) 1981-10-28
CH594686A5 (xx) 1978-01-31
ZM3674A1 (en) 1975-11-21
YU46374A (en) 1982-06-18
PL88714B1 (en) 1976-09-30
ATA142474A (de) 1976-04-15
ES423532A1 (es) 1976-06-01
IE38916L (en) 1974-08-23
JPS56138194A (en) 1981-10-28
BR7401385D0 (pt) 1974-11-05
HK19980A (en) 1980-04-25
CS189625B2 (en) 1979-04-30
FR2218878B1 (xx) 1977-03-11
JPS613358B2 (xx) 1986-01-31
AU6591574A (en) 1975-08-28
ZA741190B (en) 1975-09-24
NO792609L (no) 1974-08-26
NL181010B (nl) 1987-01-02
FI63240C (fi) 1983-05-10
YU37347B (en) 1984-08-31
YU36971B (en) 1984-08-31

Similar Documents

Publication Publication Date Title
NO141407C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive etylenderivater
NO143218C (no) Analogifremgangsmaate til fremstilling av nonapeptidamider med lh-rh aktivitet
SE413405B (sv) Analogiforfarande for framstellning av pyridazinonforeningar
NO145240C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme o-substituerte 7beta-acylamino-3-cefem-3-ol-4-karboksylsyre-forbindelser
NO149281C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 7alfa-metoksycephalosporinderivater
NO145056C (no) (s)-1-aryloksy-2-propanolderivater for fremstilling av terapeutisk aktive (s)-1-aryloksy-3-amino-2-propanolderivater
NO148375C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme 3-klor-7-alfa-amino-acylcefalosporinforbindelser
NO142303C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme oksazolderivater
NO141850C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive pyrazolderivater.
NO141755C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme dotriacontapeptidamider
NO143064C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive hydroksyalkylxantiner
NO146596C (no) Fremgangsmaate for fremstilling av 6-deoksytetracykliner
SE417601B (sv) Forfarande for framstellning av amidinokarbamider
NO141160C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme 3,4-dihydro-2(1h)-isokinolinkarboksamider
NO843825L (no) Fremgangsmaate for fremstilling av 6-deoksytetracyklin
NO141208C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme 2-(fenoksyalkyltio)imidazolforbindelser
NO148376C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme 7-acylamino-3-halogen-cefalosporinforbindelser
SE417319B (sv) Analogiforfarande for framstellning av ergopeptiner
NO141441C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive derivater av isoindolin-1-on
NO144704C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1-alkyl-2-(fenoksymetyl)-5-nitro-imidazoler
NO142669C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive, heterocykliske forbindelser
SE409994B (sv) Forfarande for framstellning av amidinokarbamider
NO143845C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme 3-amino-pyrrolderivater
NO140104C (no) Analogifremgangsmaate til fremstilling av 17beta-hydroksy-16,16-dimetylestr-4-en-3-on med terapeutisk aktivitet
NO144018C (no) Fremgangsmaate for fremstilling av heterocykliske forbindelser